Laurion Capital Management LP Adicet Bio, Inc. Transaction History

Laurion Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$7.72 - $21.27 $458,035 - $1.26 Million	-59,331 Reduced 65.31%	31,518 $281,000
Q3 2022 Nov 14, 2022	SELL	$13.43 - $18.74 $4.71 Million - $6.57 Million	-350,669 Reduced 79.42%	90,849 $1.29 Million
Q1 2022 May 16, 2022	SELL	$11.53 - $19.97 $847,247 - $1.47 Million	-73,482 Reduced 14.27%	441,518 $8.82 Million
Q4 2021 Feb 14, 2022	BUY	$7.37 - $17.49 $1.77 Million - $4.2 Million	240,000 Added 87.27%	515,000 $9.01 Million
Q2 2021 Aug 13, 2021	SELL	$9.19 - $15.93 $609,012 - $1.06 Million	-66,269 Reduced 19.42%	275,000 $2.83 Million
Q1 2021 May 14, 2021	BUY	$12.12 - $17.17 $4.14 Million - $5.86 Million	341,269 New	341,269 $4.46 Million

59.2M

4.2K

6.7K

Ticker ACET
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,030,800
Market Cap $36M
Description
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.